"anti cancer treatment" trang 2 - tải miễn phí từ tailieunhanh
Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma
7    37    1
Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol

Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol
7    59    0
The PANDA study: A randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients

The PANDA study: A randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
11    78    1
Differential associations of proinflammatory and anti-inflammatory cytokines with depression severity from noncancer status to breast cancer course and subsequent chemotherapy

Differential associations of proinflammatory and anti-inflammatory cytokines with depression severity from noncancer status to breast cancer course and subsequent chemotherapy
9    41    1
The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages

The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages
10    53    1
Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer
10    38    1
A VELOUR post hoc subset analysis: Prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI

A VELOUR post hoc subset analysis: Prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI
9    36    1
Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)

Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)
7    1    1
Characteristics of HER2-positive breast cancer, and the current use of anti HER2 therapy and its related factors

Characteristics of HER2-positive breast cancer, and the current use of anti HER2 therapy and its related factors
8    1    1
Characteristics of HER2-positive breast cancer, and the current use of anti HER2 therapy and its related factors

Characteristics of HER2-positive breast cancer, and the current use of anti HER2 therapy and its related factors
8    1    1
Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer

Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer
10    45    1
A 10-year retrospective study of lung cancer in Uganda

A 10-year retrospective study of lung cancer in Uganda
8    24    1
Successful treatment with antiprogrammed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: A case report

Successful treatment with antiprogrammed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: A case report
5    43    1
Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma - a suitable treatment option: Case report and review of anti-angiogenic treatment options

Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma - a suitable treatment option: Case report and review of anti-angiogenic treatment options
5    42    1
CABOCOL-01 trial: A single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure

CABOCOL-01 trial: A single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
12    31    1
Anti-PD-1 combined sorafenib versus antiPD-1 alone in the treatment of advanced hepatocellular cell carcinoma: A propensity score-matching study

Anti-PD-1 combined sorafenib versus antiPD-1 alone in the treatment of advanced hepatocellular cell carcinoma: A propensity score-matching study
8    27    3
Modeling and optimization of nanoemulsion containing Sorafenib for cancer treatment by response surface methodology

Modeling and optimization of nanoemulsion containing Sorafenib for cancer treatment by response surface methodology
9    87    0
Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report
4    38    1
Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electrohyperthermia

Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electrohyperthermia
13    79    1
Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells

Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells
11    31    1